American Society of Hirudotherapy

Treatment Protocol for Compromised Nasal Skin

Research article published in Facial plastic surgery clinics of North America (2019)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewClinical TrialsKerolus J, Nassif P · Facial plastic surgery clinics of North America, 2019

Abstract

As the number of patients seeking surgical and nonsurgical rhinoplasty continues to increase, the risk of nasal skin compromise after surgery also has risen. Vascular insult to the nasal skin envelope can lead to permanent disfigurement that is nearly impossible to correct. Tissue loss often requires major reconstruction that yields suboptimal cosmetic results. This article discusses prevention, early recognition, and effective treatment that aim to mitigate skin necrosis and the resulting soft tissue destruction.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAdministration, CutaneousAnti-Bacterial AgentsHumansHyperbaric OxygenationLeechingNecrosisNitroglycerinNosePostoperative ComplicationsRhinoplastyRisk FactorsSkin

Summary

As the number of patients seeking surgical and nonsurgical rhinoplasty continues to increase, the risk of nasal skin compromise after surgery also has risen.

Why This Matters for Hirudotherapy

This review addresses prevention, early recognition, and treatment of nasal skin compromise after surgical and nonsurgical rhinoplasty, a complication involving vascular insult that can result in permanent disfigurement and suboptimal reconstructive outcomes. The topic is only indirectly relevant to hirudotherapy: tissue ischemia and necrosis represent the type of vascular compromise for which leech therapy has been used clinically, yet the abstract makes no mention of leeching, leech-derived agents, or hirudotherapy in any capacity. Without supporting detail from the abstract, any connection to the leech salivary secretome or to ASH's specific domain remains speculative, and the article's direct relevance to hirudotherapy cannot be assumed.

Citation

Treatment Protocol for Compromised Nasal Skin.

Kerolus J, Nassif P · Facial plastic surgery clinics of North America, 2019

Added to ASH library: March 18, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.